Evolut R System for transcatheter aortic valve replacement (TAVR)

The Evolut™ R valve was built on the proven design of our CoreValve™ platform and features a supra-annular, self-expanding nitinol frame with a low delivery profile.

Download brochure


Medtronic transcatheter aortic valve in the native anatomy

Explore the Evolut R System

The Evolut R transcatheter aortic heart valve can be recaptured and repositioned. Its self-expanding nitinol frame enhances the ability to conform and seal to the native annulus. The supra-annular leaflet position keeps the working portion of the valve above and unconstrained by the native annulus.

See how the Evolut R valve is made

Product details

Designed to be durable

The Evolut R valve is built on a proven platform that continues to demonstrate exceptional outcomes. Design elements that support durable performance include:

  • Strong, pliable porcine pericardial tissue promotes durability and low-profile delivery.

  • Self-expanding nitinol frame conforms and adapts to the annulus, applying consistent outward radial force.

  • Supra-annular valve design maximizes the valve orifice and leaflet coaptation for single-digit gradients and large effective orifice areas (EOAs).1
Evolut valve from side and top views showing the ability of the valve to conform to noncircular anatomy

TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker.

Manuals and technical guides

Access instructions for use and other technical manuals in the Medtronic Manual Library. Search by the product name (e.g., Evolut) or model number. You may also call 800-961-9055 for a copy of a manual.


Stay up to date

Follow us on Twitter @MDT_StructHeart and subscribe for email updates about TAVR innovations.

Get support

Reach out to LifeLine CardioVascular Tech Support with questions.


Education and resources

Find more detailed TAVR information, educational resources, and tools.



Popma JJ, Reardon MJ, Khabbaz K, et al. Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study. JACC Cardiovasc IntervFebruary 13, 2017;10(3):268-275.